A whole-genome RNAi screen identifies an 8q22 gene cluster that inhibits death receptor-mediated apoptosis

Area of Science:

• Oncology
• Molecular Biology
• Cancer Genetics

Background:

• Deregulation of apoptosis is a hallmark of cancer, prompting research into novel therapeutic agents targeting this cell death pathway.
• Understanding mechanisms of apoptosis evasion is crucial for developing effective cancer treatments.

Purpose of the Study:

• To identify genes that modulate sensitivity to death receptor-induced apoptosis using a pooled shRNA screen.
• To investigate the role of EDD1 and GRHL2 in apoptosis regulation and their potential as therapeutic targets in cancer.

Main Methods:

• Conducted a pooled shRNA screen to identify genes affecting ligand-induced apoptosis.
• Performed gene silencing and overexpression studies to elucidate the function of EDD1 and GRHL2.
• Analyzed gene expression and copy number alterations in cancer cell lines.

Main Results:

• Identified 16 genes modulating apoptosis sensitivity, with several overexpressed or amplified in cancer.
• Discovered that EDD1 and GRHL2 suppress death-receptor expression and are located in a frequently amplified region (8q22).
• Demonstrated that EDD1 is elevated in resistant cancer cell lines, and silencing EDD1 or GRHL2 sensitizes cells to apoptosis.

Conclusions:

• EDD1 and GRHL2 represent a novel mechanism by which cancer cells evade apoptosis.
• Targeting EDD1 and GRHL2 could be a viable strategy to re-sensitize cancer cells to apoptosis-inducing therapies.
• These genes may serve as biomarkers for predicting response to apoptosis-targeting drugs.